spacer
home > epc > winter 2003 > editor's letter
PUBLICATIONS
European Pharmaceutical Contractor

Editor's Letter

Welcome to the latest edition of EPC - winter seems to have appeared very suddenly!

I am pleased that we have a keynote article in this issue from Trevor Jones of the Association of the British Pharmaceutical Industry, in which he highlights issues of importance to the whole industry. The article considers the World Trade Organization's deal concerning the provision of generic drugs in less developed areas of the world. He highlights how industry works in partnership with public organisations to find ways to treat diseases in those areas. He also emphasises that it is not just the provision of treatments which is important - there needs to be an adequate infrastructure to ensure that diseases are efficiently diagnosed and then treated.


Partnerships designed to solve health problems are also identified in an article from John Savopoulos of Datamonitor that looks back to the outbreak of SARS earlier this year. Industry mounted a quick response to this threat, and again there are instances of public bodies providing support to corporate efforts. The outbreak was effectively managed by isolation and containment to prevent its spread, and this highlights how important diagnosis of disease can be. A valuable immediate contribution of industry has been the development of a diagnostic allowing differentiation of SARS infected patients from those with other viral diseases such as flu - this can quickly contribute to the isolation and containment effort.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Julia Lloyd-Parks
spacer
Julia Lloyd-Parks
spacer
spacer
spacer
John White
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Dynascan Discusses Company Advancements With Packaging Today Magazine

Dynascan’s Marketing Manager (MM) recently met up with Europe’s leading packaging magazine, Packaging Today. During the interview many topics were covered, and you can read the full article here, but below are a few highlights and brief summary of what was discussed…
More info >>

White Papers

Clinical Trial Disclosure Management: Build vs. Buy

TrialScope

Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement